RELY

Randomized Evaluation of Long-term Anticoagulant Therapy Comparing the Efficacy and Safety of Two Blinded Doses of Dabigatran Etexilate with Open-label Warfarin for the Prevention of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation: Prospective, Multicenter, Parallel-group, Non-inferiority Trial

Summary: The primary objective of this trial is to demonstrate the efficacy of dabigatran etexilate in patients with non-valvular atrial fibrillation for the prevention of stroke and systemic embolism, as compared with the standard treatment of such condition with warfarin.

<< Back